Stockreport

TriSalus Life Sciences to Host Virtual KOL Event to Discuss the TriNav Infusion System for the Treatment of Symptomatic Thyroid Disease on December 15, 2025 [Yahoo! Finance]

TriSalus Life Sciences, Inc.  (TLSI) 
PDF WESTMINSTER, Colo., December 04, 2025 BUSINESS WIRE )--TriSalus Life Sciences, Inc. (Nasdaq: TLSI) ("TriSalus" or the "Company"), an oncology company integrating novel d [Read more]